{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T18:06:14Z","timestamp":1770487574807,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,23]],"date-time":"2017-09-23T00:00:00Z","timestamp":1506124800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s10072-017-3119-y","type":"journal-article","created":{"date-parts":[[2017,9,23]],"date-time":"2017-09-23T07:11:33Z","timestamp":1506150693000},"page":"31-44","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Intranasal sumatriptan for acute migraine attacks: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"39","author":[{"given":"Amr","family":"Menshawy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussien","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ammar","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1399-6487","authenticated-orcid":false,"given":"Abdelrahman Ibrahim","family":"Abushouk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esraa","family":"Ghanem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravikishore","family":"Pallanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Negida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,23]]},"reference":[{"key":"3119_CR1","first-page":"2","volume":"65","author":"AS Rao","year":"2016","unstructured":"Rao AS, Gelaye B, Kurth T et al (2016) A randomized trial of ketorolac vs sumatripan vs placebo nasal spray (KSPN) for acute migraine. Headache 65:2","journal-title":"Headache"},{"key":"3119_CR2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.molmed.2006.11.005","volume":"13","author":"PJ Goadsby","year":"2006","unstructured":"Goadsby PJ (2006) Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol Med 13:39\u201344","journal-title":"Trends Mol Med"},{"key":"3119_CR3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10072-014-1903-5","volume":"36","author":"F Baldacci","year":"2015","unstructured":"Baldacci F, Lucchesi C, Ulivi M et al (2015) Clinical features associated with ictal osmophobia in migraine. Neurol Sci 36:43\u201346","journal-title":"Neurol Sci"},{"key":"3119_CR4","doi-asserted-by":"crossref","unstructured":"Derry CJ, Derry S, Moore RA (2014) Sumatriptan (intranasal route of administration) for acute migraine attacks in adults. The Cochrane Library-Wiley Online Library","DOI":"10.1002\/14651858.CD009108.pub2"},{"key":"3119_CR5","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1007\/s10072-016-2705-8","volume":"37","author":"A Raggi","year":"2016","unstructured":"Raggi A, Covelli V, Schiavolin S et al (2016) Psychosocial difficulties in patients with episodic migraine: a cross-sectional study. Neurol Sci 37:1979\u20131986","journal-title":"Neurol Sci"},{"key":"3119_CR6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10072-017-2814-z","volume":"38","author":"M Foti","year":"2017","unstructured":"Foti M, Lo V, Francesco B et al (2017) Neuropsychological assessment in migraine patients: a descriptive review on cognitive implications. Neurol Sci 38:553\u2013562","journal-title":"Neurol Sci"},{"key":"3119_CR7","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1468-2982.2002.00359.x","volume":"22","author":"NN Vachharajani","year":"2002","unstructured":"Vachharajani NN, Shyu W, Nichola PS, Boulton DW (2002) A pharmacokinetic interaction study between butorphanol and sumatriptan nasal sprays in healthy subjects: importance of the timing of butorphanol administration. Cephalalgia 22:282\u2013287","journal-title":"Cephalalgia"},{"key":"3119_CR8","first-page":"99","volume":"6","author":"C Duquesnoy","year":"1998","unstructured":"Duquesnoy C, Mamet JP, Sumner D, Fuseau E (1998) Comparative clinical pharmacokinetics of single doses of sumatriptan following subcutaneous, oral, rectal and intranasal administration. Eur J Neurol 6:99\u2013104","journal-title":"Eur J Neurol"},{"key":"3119_CR9","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/head.12167","volume":"53","author":"M Obaidi","year":"2013","unstructured":"Obaidi M, Offman E, Messina J et al (2013) Improved pharmacokinetics of sumatriptan with Breath Powered\u2122 nasal delivery of sumatriptan powder. Headache 53:1323\u20131333","journal-title":"Headache"},{"key":"3119_CR10","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s10072-017-2888-7","volume":"38","author":"V Villani","year":"2017","unstructured":"Villani V, Prosperini L, Palombini F, Orzi F (2017) Single-blind, randomized, pilot study combining shiatsu and amitriptyline in refractory primary headaches. Neurol Sci 38:999\u20131007","journal-title":"Neurol Sci"},{"key":"3119_CR11","first-page":"39","volume":"70","author":"S Wang","year":"2007","unstructured":"Wang S, Fuh J, Wu Z (2007) Intranasal sumatriptan study with high placebo response in Taiwanese patients with migraine. Chin Med J 70:39\u201346","journal-title":"Chin Med J"},{"key":"3119_CR12","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/head.12583","volume":"55","author":"RA Mahmoud","year":"2015","unstructured":"Mahmoud RA, Djupesland PG, Shin P, Siffert J (2015) Containing 22\u00a0mg sumatriptan powder vs 100\u00a0mg oral sumatriptan in the acute treatment of migraines (the COMPASS study): a comparative randomized clinical trial across multiple attacks. Headache 55:621\u2013635","journal-title":"Headache"},{"key":"3119_CR13","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1212\/WNL.49.5.1225","volume":"49","author":"R Ryan","year":"1997","unstructured":"Ryan R, Elkind A, Baker CC, Mullican W, DeBussey S, Asgharnejad M (1997) Sumatriptan nasal spray for the acute treatment of migraine results of two clinical studies. Neurology 49:1225\u20131230","journal-title":"Neurology"},{"key":"3119_CR14","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097","journal-title":"PLoS Med"},{"key":"3119_CR15","doi-asserted-by":"crossref","unstructured":"Higgins JP, Green S (2008) Cochrane handbook for systematic reviews of interventions: Cochrane book series. Wiley and Sons, Hoboken","DOI":"10.1002\/9780470712184"},{"key":"3119_CR16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-2982.2003.00824.x","volume":"24","author":"The International Headache Society: Subcommittee of Headache Classification","year":"2004","unstructured":"The International Headache Society: Subcommittee of Headache Classification (2004) The international classification of headache disorders. Cephalalgia 24:9","journal-title":"Cephalalgia"},{"key":"3119_CR17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634","journal-title":"BMJ"},{"key":"3119_CR18","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/sim.1461","volume":"22","author":"N Terrin","year":"2003","unstructured":"Terrin N, Schmid CH, Lau J, Olkin I (2003) Adjusting for publication bias in the presence of heterogeneity. Stat Med 22:2113\u20132126","journal-title":"Stat Med"},{"key":"3119_CR19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/head.12472","volume":"55","author":"RK Cady","year":"2015","unstructured":"Cady RK, McAllister PJ, Spierings ELH et al (2015) A randomized, double- blind, placebo- controlled study of breath powered nasal delivery of Sumatriptan powder (AVP- 825) in the treatment of acute migraine (the TARGET study). Headache 55:88\u2013100","journal-title":"Headache"},{"key":"3119_CR20","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1177\/0333102409359314","volume":"30","author":"PG Djupesland","year":"2010","unstructured":"Djupesland PG, Do\u010dekal P (2010) Intranasal sumatriptan powder delivered by a novel breath-actuated bi-directional device for the acute treatment of migraine: a randomised, placebo-controlled study. Cephalalgia 30:933\u2013942","journal-title":"Cephalalgia"},{"key":"3119_CR21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF00919706","volume":"241","author":"R Salonen","year":"1994","unstructured":"Salonen R, Ashford E, Dahl\u00f6f C et al (1994) Intranasal sumatriptan for the acute treatment of migraine. J Neurol 241:463\u2013469","journal-title":"J Neurol"},{"key":"3119_CR22","doi-asserted-by":"crossref","unstructured":"Salonen R, Farkkila M, Havanka H, et al (1991) A placebo-controlled study of intranasal sumatriptan for the acute treatment of migraine. Eur J Neurol 31:332\u2013338","DOI":"10.1159\/000116761"},{"key":"3119_CR23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1526-4610.2006.00339.x","volume":"46","author":"P Winner","year":"2006","unstructured":"Winner P, Rothner AD, Wooten JD et al (2006) Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study. Headache 46:212\u2013222","journal-title":"Headache"},{"key":"3119_CR24","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1212\/01.WNL.0000115105.05966.A7","volume":"62","author":"K Ahonen","year":"2004","unstructured":"Ahonen K, H\u00e4m\u00e4l\u00e4inen ML, Rantala H, Hoppu K (2004) Nasal sumatriptan is effective in treatment of migraine attacks in children: a randomized trial. Neurology 62:883\u2013887","journal-title":"Neurology"},{"key":"3119_CR25","unstructured":"S2B-340 A double-blind, placebo-controlled, parallel-group study to evaluate two dose levels (10\u00a0mg and 20\u00a0mg) of sumatriptan nasal spray in the acute treatment of a migraine attack with an optional repeat dose for headache recurrence. https:\/\/www.gskclinicalstudyregister.com\/"},{"key":"3119_CR26","unstructured":"SUM40031 A randomised double-blind, double-dummy, single-attack, parallel group study to compare the speed of onset of sumatriptan nasal spray (20\u00a0mg) with rizatriptan wafer (10\u00a0mg) in the acute treatment of migraine. https:\/\/www.gskclinicalstudyregister.com\/"},{"key":"3119_CR27","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1742-1241.2000.tb11905.x","volume":"54","author":"F Boureau","year":"2000","unstructured":"Boureau F, Kappos L, Schoenen J et al (2000) A clinical comparison of sumatriptan nasal spray and dihydroergotamine nasal spray in the acute treatment of migraine. Int J clinic Pract 54:281\u2013286","journal-title":"Int J clinic Pract"},{"key":"3119_CR28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1468-1331.1999.610043.x","volume":"6","author":"A Peikert","year":"1999","unstructured":"Peikert A, Becker WJ, Ashford EA et al (1999) Sumatriptan nasal spray: a dose-ranging study in the acute treatment of migraine. Eur J Neurol 6:43\u201349","journal-title":"Eur J Neurol"},{"key":"3119_CR29","doi-asserted-by":"crossref","unstructured":"Diamond, Seymour, et al (1998) Multiple-attack efficacy and tolerability of sumatriptan nasal spray in the treatment of migraine.\" Archives of family medicine 7: 234\u2013240","DOI":"10.1001\/archfami.7.3.234"},{"key":"3119_CR30","doi-asserted-by":"crossref","unstructured":"Cj D, Derry S, Ra M (2014) Sumatriptan (all routes of administration ) for acute migraine attacks in adults\u2014overview of Cochrane reviews (review). The Cochrane Library-Wiley Online library","DOI":"10.1002\/14651858.CD009108.pub2"},{"key":"3119_CR31","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s10072-017-2854-4","volume":"38","author":"K Ikeda","year":"2017","unstructured":"Ikeda K, Hanashiro S, Ishikawa Y, Sawada M (2017) Treatment with telmisartan, a long-acting angiotensin II receptor blocker, prevents migraine attacks in Japanese non-responders to lomerizine. Neurol Sci 38:827\u2013831","journal-title":"Neurol Sci"},{"key":"3119_CR32","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s10072-016-2568-z","volume":"37","author":"M Russo","year":"2016","unstructured":"Russo M, Camillo G, Arens M, Antonio T (2016) The use of onabotulinum toxin A (Botox \u00d2) in the treatment of chronic migraine at the Parma Headache Centre: a prospective observational study. Neurol Sci 37:1127\u20131131","journal-title":"Neurol Sci"},{"key":"3119_CR33","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10072-017-2861-5","volume":"38","author":"L Ertug","year":"2017","unstructured":"Ertug L (2017) Do bilateral and unilateral greater occipital nerve block effectiveness differ in chronic migraine patients? Neurol Sci 38:949\u2013954","journal-title":"Neurol Sci"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-017-3119-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-017-3119-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-017-3119-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T08:31:47Z","timestamp":1693038707000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-017-3119-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,23]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["3119"],"URL":"https:\/\/doi.org\/10.1007\/s10072-017-3119-y","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,23]]}}}